Cefalexin use in UK acute pyelonephritis practice: unaddressed challenges in dosing, breakpoints and clinical evidence.

Hughes S, Livermore DM, Boyd SE, Kahlmeter G, Teale C, Burns P, Brown NM, Macgowan A, BSAC Standing Committee on Antimicrobial Susceptibility Testing

Open source

DOI: 10.1093/jac/dkag051
Published: 2026 Feb 2
Container: The Journal of antimicrobial chemotherapy
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jac/dkag051,
  title = {Cefalexin use in UK acute pyelonephritis practice: unaddressed challenges in dosing, breakpoints and clinical evidence.},
  author = {Hughes S and Livermore DM and Boyd SE and Kahlmeter G and Teale C and Burns P and Brown NM and Macgowan A and BSAC Standing Committee on Antimicrobial Susceptibility Testing},
  year = {2026},
  journal = {The Journal of antimicrobial chemotherapy},
  doi = {10.1093/jac/dkag051},
  url = {https://doi.org/10.1093/jac/dkag051}
}

RIS

TY  - JOUR
TI  - Cefalexin use in UK acute pyelonephritis practice: unaddressed challenges in dosing, breakpoints and clinical evidence.
AU  - Hughes S
AU  - Livermore DM
AU  - Boyd SE
AU  - Kahlmeter G
AU  - Teale C
AU  - Burns P
AU  - Brown NM
AU  - Macgowan A
AU  - BSAC Standing Committee on Antimicrobial Susceptibility Testing
PY  - 2026
JO  - The Journal of antimicrobial chemotherapy
DO  - 10.1093/jac/dkag051
UR  - https://doi.org/10.1093/jac/dkag051
ER  -

APA

S, H., DM, L., SE, B., G, K., C, T., P, B., NM, B., A, M., & Testing, B. S. C. O. A. S. (2026). Cefalexin use in UK acute pyelonephritis practice: unaddressed challenges in dosing, breakpoints and clinical evidence.. The Journal of antimicrobial chemotherapy. https://doi.org/10.1093/jac/dkag051

Source records

pubmed · retrieved 2026-09-25T20:16:18.727Z